Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medication risk assessment system

A risk assessment system and risk technology, applied in the field of medical diagnosis and treatment system design, can solve problems such as irregular disease treatment, shortage of medical resources, and weak awareness of patients' rational use of drugs, and achieve the effect of intuitively prompting systemic risks.

Inactive Publication Date: 2019-01-18
FUJIAN UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the incomplete laws and regulations and measures related to drug supervision in my country, the shortage of medical resources in some remote and poor areas, the non-standard treatment of diseases, and the weak awareness of rational drug use in patients will lead to clinical treatment of cerebral infarction. Irrational use of medication

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medication risk assessment system
  • Medication risk assessment system
  • Medication risk assessment system

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020] In order to explain in detail the technical content, structural features, achieved goals and effects of the technical solution, the following will be described in detail in conjunction with specific embodiments and accompanying drawings.

[0021] see figure 1 , is a medication risk assessment method in the present invention. This embodiment includes the following steps. S100 collects risk prescription information, and the risk medication information includes risk prescription information, risk accumulation time information, and risk medication times. S102 substitutes risk medication information into The classic parameter model of AMSAA reliability growth is evaluated, and S104 obtains the evaluation result of system reliability growth. In our example, medication risk is an objective situation assessment relative to human-operated medication conditions. Therefore, if there are scientific means to conduct stable and objective assessment, it will help improve the treatment...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a medication risk assessment system comprising an information collection module and a reliability growth assessment module. The information collection module is used for collecting risk medication information, wherein the risk medication information includes the risk prescription information, the risk accumulation time information and the risk medication times. The reliability growth assessment module is used for substituting the risk medication information into the reliability growth classic parameter model for assessment to obtain the mean time between failures so as to further obtain the system reliability growth assessment result. According to the technical scheme, the reliability growth classic parameter model is introduced to perform assessment so as to providetechnical indicators for risk prevention and control in the entire medical treatment system and provide visual suggestions for medical medication management. The reliability of each risk is calculated so as to achieve the effect of visually prompting the systemic risk.

Description

technical field [0001] The invention relates to the field of medical diagnosis and treatment system design, in particular to a medication risk assessment system caused by human risks in the diagnosis and treatment process. Background technique [0002] The phenomenon of irrational drug use still exists in the actual clinical treatment in my country, which is reflected in the use of contraindicated drugs, overdose, repeated drug use, and irrational combination of drugs for special groups [3]. Irrational drug use can be summed up as all unsafe, effective, economical and appropriate drug use caused by human factors [4]. This study focuses on the clinical drug use in the recovery period of cerebral infarction, that is, the rational drug use in the recovery period of stroke. Cerebrovascular disease (Cerebrovascular Disease, CVD) ranks third among the causes of death in the world, is also the leading cause of adult disability, and is also one of the important causes of cognitive ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G16H20/10G16H50/20
CPCG16H20/10G16H50/20
Inventor 黄至辉甘志超张冬雪代凯唐迎春林泓叶守强
Owner FUJIAN UNIV OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com